Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.

de Rooy JW, Hambrock T, Vriens D, Flucke UE, van der Geest IC, van de Luijtgaarden AC, Schreuder BW, de Geus-Oei LF.

Clin Nucl Med. 2011 Jul;36(7):565-7. doi: 10.1097/RLU.0b013e318217561c.

PMID:
21637060
[PubMed - indexed for MEDLINE]
2.

Bone infarct-associated sarcoma detected on FDG PET/CT.

Dua SG, Purandare N, Shah S, Sharma AR, Zade AA, Rangarajan V.

Clin Nucl Med. 2011 Mar;36(3):218-20. doi: 10.1097/RLU.0b013e318208f30e.

PMID:
21285682
[PubMed - indexed for MEDLINE]
3.

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M, Ruf J, Furth C, Stöver B, Hautzel H, Henze G, Amthauer H.

J Clin Oncol. 2007 Dec 1;25(34):5435-41.

PMID:
18048826
[PubMed - indexed for MEDLINE]
Free Article
4.

F-18 FDG PET-CT imaging in gastric sarcoma.

Gamble B, Meka M, Ho L.

Clin Nucl Med. 2009 Sep;34(9):564-5. doi: 10.1097/RLU.0b013e3181b06b57.

PMID:
19692814
[PubMed - indexed for MEDLINE]
5.

FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.

Charest M, Hickeson M, Lisbona R, Novales-Diaz JA, Derbekyan V, Turcotte RE.

Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1944-51. doi: 10.1007/s00259-009-1203-0.

PMID:
19593561
[PubMed - indexed for MEDLINE]
6.

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, Tosi P, Tacchetti P, Cangini D, Perrone G, Ceccolini M, Brioli A, Buttignol S, Fanin R, Salizzoni E, Baccarani M, Fanti S, Cavo M.

Haematologica. 2007 Jan;92(1):50-5.

PMID:
17229635
[PubMed - indexed for MEDLINE]
Free Article
7.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
8.

Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.

Arush MW, Israel O, Postovsky S, Militianu D, Meller I, Zaidman I, Sapir AE, Bar-Shalom R.

Pediatr Blood Cancer. 2007 Dec;49(7):901-5.

PMID:
17252575
[PubMed - indexed for MEDLINE]
9.

[Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].

Schramm N, Schlemmer M, Rist C, Issels R, Reiser MF, Berger F.

Radiologe. 2010 Apr;50(4):339-48. doi: 10.1007/s00117-009-1973-1. German.

PMID:
20221579
[PubMed - indexed for MEDLINE]
10.

Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Denecke T, Hundsdörfer P, Misch D, Steffen IG, Schönberger S, Furth C, Plotkin M, Ruf J, Hautzel H, Stöver B, Kluge R, Bierbach U, Otto S, Beck JF, Franzius C, Henze G, Amthauer H.

Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1842-53. doi: 10.1007/s00259-010-1484-3. Epub 2010 May 27.

PMID:
20505933
[PubMed - indexed for MEDLINE]
11.

Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.

Sung PL, Chen YJ, Liu RS, Shieh HJ, Wang PH, Yen MS, Wen KC, Shen SH, Lai CR, Yuan CC.

Eur J Gynaecol Oncol. 2008;29(3):246-51.

PMID:
18592788
[PubMed - indexed for MEDLINE]
12.

Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.

Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.

Cancer. 2009 Dec 1;115(23):5470-80. doi: 10.1002/cncr.24599.

PMID:
19739235
[PubMed - indexed for MEDLINE]
Free Article
13.

Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-up.

Freudenberg LS, Antoch G, Beyer T, Görges R, Debatin JF, Bockisch A.

Clin Nucl Med. 2003 Aug;28(8):636-7.

PMID:
12897646
[PubMed - indexed for MEDLINE]
14.

Contemporary imaging in sarcoma.

Landa J, Schwartz LH.

Oncologist. 2009 Oct;14(10):1021-38. doi: 10.1634/theoncologist.2009-0194. Epub 2009 Sep 29.

PMID:
19789392
[PubMed - indexed for MEDLINE]
Free Article
15.

FDG PET/CT flip flop phenomenon in treated lymphoma of bone.

Lin EC.

Clin Nucl Med. 2006 Dec;31(12):803-5.

PMID:
17117078
[PubMed - indexed for MEDLINE]
16.

Pulmonary artery sarcoma detected on F-18 FDG PET/CT as origin of multiple spinal metastases.

Chun IK, Eo JS, Paeng JC, Kim DW, Chung JK, Lee DS.

Clin Nucl Med. 2011 Aug;36(8):e87-9. doi: 10.1097/RLU.0b013e318217ae58.

PMID:
21716007
[PubMed - indexed for MEDLINE]
17.

Improved staging with pretreatment positron emission tomography/computed tomography in low rectal cancer.

Gearhart SL, Frassica D, Rosen R, Choti M, Schulick R, Wahl R.

Ann Surg Oncol. 2006 Mar;13(3):397-404. Epub 2006 Jan 30.

PMID:
16485158
[PubMed - indexed for MEDLINE]
18.

Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.

Basu S, Li G, Bural G, Alavi A.

Acta Radiol. 2009 Mar;50(2):201-4. doi: 10.1080/02841850802620689.

PMID:
19089692
[PubMed - indexed for MEDLINE]
19.

F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound.

von Falck C, Rodt T, Joerdens S, Waldeck S, Kiesel H, Knapp WH, Galanski M.

Clin Nucl Med. 2009 Aug;34(8):493-5. doi: 10.1097/RLU.0b013e3181abb6ba.

PMID:
19617723
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk